13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q4 2019. See the latest, Q2 2026 →
Reported value
$956.78B
+123% on the quarter before
Positions
4,207
177 new · 164 sold out
Top 10
18.6%
of the value
Est. gain
+$35.32B
on stocks held all quarter
Est. return
+8.3%
on those stocks since Q3 2019
Positions as of Dec 31, 2019, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.
Largest buys
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$18.76BAdded · 3.5% → 3.7%+119,172,742 shares
- Apple~$18.54BAdded · 3.2% → 3.8%+63,271,836 shares
- Amazon~$11.23BAdded · 2.3% → 2.3%+6,089,773 shares
- Meta~$7.17BAdded · 1.4% → 1.5%+34,998,654 shares
- Alphabet~$6.40BAdded · 1.3% → 1.3%+4,788,988 shares
- Berkshire Hathaway Inc-Cl B~$6.33BAdded · 1.3% → 1.3%+27,986,109 shares
- Jpmorgan Chase & Co~$6.26BAdded · 1.2% → 1.3%+45,007,169 shares
- Alphabet~$5.80BAdded · 1.2% → 1.2%+4,346,296 shares
- Johnson & Johnson~$5.79BAdded · 1.1% → 1.2%+39,757,107 shares
- Procter & Gamble Co/The~$5.31BAdded · 1.2% → 1.1%+42,612,984 shares
Largest sells
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Celgene Corp~$1.15BSold out · 0.3% → 0.0%−11,574,438 shares
- Bb&T Corp~$549.5MSold out · 0.1% → 0.0%−10,313,749 shares
- Suntrust Banks Inc~$465.9MSold out · 0.1% → 0.0%−6,781,576 shares
- Hcp Inc~$328.1MSold out · 0.1% → 0.0%−9,220,441 shares
- Symantec Corp~$208.4MSold out · 0.0% → 0.0%−8,831,757 shares
- Cbs Corp-Class B Non Voting~$199.3MSold out · 0.0% → 0.0%−4,943,388 shares
- Viacom Inc-Class B~$138.7MSold out · 0.0% → 0.0%−5,775,898 shares
- Genesee & Wyoming Inc-Cl A~$66.5MSold out · 0.0% → 0.0%−601,470 shares
- Medidata Solutions Inc~$62.3MSold out · 0.0% → 0.0%−680,361 shares
- Versum Materials Inc~$60.3MSold out · 0.0% → 0.0%−1,139,167 shares
Holdings
As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +103% · price +31.0% | 3.8% | $36.62B | +$4.28B | ||||||||
| MicrosoftCOM · shares +111% · price +13.4% | 3.7% | $35.70B | +$2.00B | ||||||||
| AmazonCOM · shares +107% · price +6.4% | 2.3% | $21.76B | +$632.5M | ||||||||
| MetaCL A · shares +105% · price +15.2% | 1.5% | $13.96B | +$896.1M | ||||||||
| AlphabetCAP STK CL A · shares +105% · price +9.6% | 1.3% | $12.51B | +$536.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares +103% · price +18.4% | 1.3% | $12.36B | +$946.4M | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +106% · price +8.8% | 1.3% | $12.31B | +$485.8M | ||||||||
| AlphabetCAP STK CL C · shares +104% · price +9.6% | 1.2% | $11.35B | +$487.5M | ||||||||
| Johnson & JohnsonCOM · shares +107% · price +12.7% | 1.2% | $11.18B | +$606.8M | ||||||||
| Procter & Gamble Co/TheCOM · shares +106% · price +0.4% | 1.1% | $10.32B | +$18.2M | ||||||||
| Visa Inc.COM CL A · shares +106% · price +9.2% | 1.1% | $10.21B | +$417.7M | ||||||||
| Exxon Mobil CorpCOM · shares +106% · price −1.2% | 0.90% | $8.63B | −$52.2M | ||||||||
| AT&TCOM · shares +108% · price +3.2% | 0.89% | $8.54B | +$128.4M | ||||||||
| MastercardCL A · shares +105% · price +9.9% | 0.87% | $8.37B | +$366.8M | ||||||||
| IntelCOM · shares +103% · price +16.1% | 0.86% | $8.25B | +$563.9M | ||||||||
| Bank Of America CorpCOM · shares +99% · price +20.7% | 0.86% | $8.20B | +$705.3M | ||||||||
| Unitedhealth Group IncCOM · shares +107% · price +35.2% | 0.82% | $7.85B | +$985.2M | ||||||||
| Verizon Communications IncCOM · shares +109% · price +1.7% | 0.80% | $7.66B | +$60.4M | ||||||||
| Walt Disney Company (The)COM DISNEY · shares +104% · price +10.9% | 0.78% | $7.50B | +$361.2M | ||||||||
| Home Depot IncCOM · shares +107% · price −5.9% | 0.76% | $7.31B | −$222.3M | ||||||||
| Merck & Co. Inc.COM · shares +103% · price +8.0% | 0.76% | $7.26B | +$263.8M | ||||||||
| Pfizer IncCOM · shares +104% · price +9.0% | 0.73% | $6.96B | +$281.9M | ||||||||
| Chevron CorpCOM · shares +106% · price +1.6% | 0.70% | $6.66B | +$49.5M | ||||||||
| Comcast Corp-Class ACL A · shares +102% · price −0.3% | 0.63% | $6.03B | −$9.1M | ||||||||
| Wells Fargo & CoCOM · shares +97% · price +6.6% | 0.62% | $5.96B | +$187.5M | ||||||||
| Total · 4,207 positions | 100% | $956.78B | +$35.32B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2019 to Q4 2019: 3,978 stocks held throughout, up $35.32B (+8.3%).
- Apple+$4.28B+31%
- Microsoft+$2.00B+13%
- Unitedhealth Group Inc+$985.2M+35%
- Jpmorgan Chase & Co+$946.4M+18%
- Meta+$896.1M+15%
- Ventas Inc−$112.0M−21%
- IBM−$142.3M−8%
- Mcdonald'S Corp−$190.3M−8%
- Home Depot Inc−$222.3M−6%
- Boeing Co/The−$383.4M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 59 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |